Clinical Trials Directory

Trials / Conditions / Recurrent Vaginal Cancer

Recurrent Vaginal Cancer

8 registered clinical trials studyying Recurrent Vaginal Cancer.

StatusTrialSponsorPhase
TerminatedDurvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
NCT03277482
Dana-Farber Cancer InstitutePhase 1
CompletedCarboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
NCT01652794
Case Comprehensive Cancer CenterPhase 1
CompletedStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT01764789
Ohio State University Comprehensive Cancer CenterN/A
CompletedTriapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
NCT00941070
National Cancer Institute (NCI)Phase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedPhase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho
NCT00335998
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1
WithdrawnColposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or
NCT01313104
Northwestern UniversityN/A